Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.25
Delayed Data
As of Jul 29
 -0.03 / -2.34%
Today’s Change
1.19
Today|||52-Week Range
1.75
-10.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash--35.2M77.5M68.0M
 
 
 
 
Short Term Investment Cash-5.0M17.2M42.3M-9.5M
 
 
 
 
 
Cash & Short Term Investments18.0M35.2M77.5M68.0M
 
 
 
 
 
 
ReceivablesReceivables2.4M1.8M1.3M3.9M
 
 
 
 
 
 
InventoriesInventories3.6M4.3M5.5M7.4M
 
 
 
 
 
 
Current AssetsOther Current Assets703.0K617.0K1.4M1.3M
 
 
 
 
 
Current Assets24.8M41.9M85.8M80.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross8.6M9.5M9.9M23.3M
 
 
 
 
 
Depreciation-5.7M-6.8M-7.4M-8.2M
 
 
 
 
 
Other Assets567.0K466.0K2.3M1.8M
 
 
 
 
 
Total Assets28.3M45.1M90.5M97.5M
 
 
 
 
 
 
LiabilitiesAccounts Payable3.5M2.8M2.4M10.4M
 
 
 
 
 
Short Term Debt0.0032.0K13.0K0.00
 
 
 
Accrued Expenses2.1M930.0K4.4M3.9M
 
 
 
 
 
Other Current Liabilities11.7M14.1M15.9M22.3M
 
 
 
 
 
Other Liabilities17.6M20.6M22.2M37.3M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.0013.0K0.000.00
 
 
Other Liabilities779.0K432.0K347.0K1.1M
 
 
 
 
 
Total Liabilities18.8M21.3M22.8M38.4M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.001.0K2.0K
 
 
 
Common Equity9.5M23.8M67.7M59.0M
 
 
 
 
 
Total Shareholder Equity9.5M23.8M67.7M59.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding101.4M143.8M178.9M193.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.